Identification of natural inhibitor from Aframomum melegueta targeting survivin and mammalian rapamycin signaling pathway in Kidney Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of natural inhibitor from Aframomum melegueta targeting survivin and mammalian rapamycin signaling pathway in Kidney Cancer

Published:2023 Issue: Volume:41 Page:101320
ISSN:2352-9148
Container-title:Informatics in Medicine Unlocked
language:en
Short-container-title:Informatics in Medicine Unlocked

Author:

Elekofehinti Olusola Olalekan^ORCID,Ajiboro Precious Ayomide,Akinjiyan Moses Orimoloye,Saliu Tolulope Peter,Ayodeji Folasade Oluwatobiloba,Ojo Funmilola Mabel,Oluwamodupe Cecilia

Publisher

Elsevier BV

Subject

Health Informatics

Reference40 articles.

1. Kidney cancer: current progress in treatment;Thakur;World J Oncol,2011

2. The metabolic basis of kidney cancer;Linehan;Cancer Discov,2019

3. Epidemiology and risk factors for kidney cancer;Scelo;J Clin Oncol : official journal of the American Society of Clinical Oncology,2018

4. Incidence and distribution of new renal cell carcinoma cases: 27-year trends from a statewide cancer registry;Alzubaidi;Journal of kidney cancer and VHL,2022

5. Epidemiology and risk factors for kidney cancer;Chow;Nat Rev Urol,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP